NASDAQ:NH NantHealth - NH Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding NantHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $1.87 +0.26 (+16.11%) (As of 03/20/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.65▼$1.8750-Day Range$1.61▼$3.8652-Week Range$1.57▼$13.05Volume3,468 shsAverage Volume9,538 shsMarket Capitalization$14.44 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability About NantHealth (NASDAQ:NH) StockNantHealth, Inc. is an evidence-based, personalized healthcare company, which engages in the provision of treatment for critical diseases such as cancer. The firm empowers treatment decisions, improves patient outcomes, validates treatment options, enables high-quality care, lowers costs, ensures appropriate reimbursement, and streamlines implementation and deployment. The company was founded by Patrick Soon-Shiong in July 2010 and is headquartered in Morrisville, NC.Read More Receive NH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address NH Stock News HeadlinesMarch 14, 2023 | americanbankingnews.comNantHealth (NASDAQ:NH) Now Covered by Analysts at StockNews.comMarch 13, 2023 | nypost.comNew Hampshire lawmaker arrested for obstructing snowplowMarch 21, 2023 | Health Sector Insight (Ad)Penny Stock Shows Big PotentialThe $4.37 trillion wellness market and the little-known penny stock to get on radar now. March 6, 2023 | finance.yahoo.comNantHealth Announces $22.5 Million New Financing with Highbridge and Nant CapitalFebruary 22, 2023 | finance.yahoo.comOpenNMS releases OpenNMS Meridian 2023 with New Cloud-enabled CapabilitiesFebruary 19, 2023 | foxnews.comNew Hampshire man indicted on fraud charges for naming nonexistent companies, dead people on loansJanuary 29, 2023 | washingtonpost.comPotential Biden challenger Marianne Williamson heads to New HampshireJanuary 16, 2023 | finance.yahoo.comNantHealth, Inc. (NH) Stock Historical Prices & Data - Yahoo FinanceMarch 21, 2023 | Health Sector Insight (Ad)Penny Stock Shows Big PotentialThe $4.37 trillion wellness market and the little-known penny stock to get on radar now. December 15, 2022 | finance.yahoo.comNantHealth Announces 1-for-15 Reverse Stock SplitNovember 9, 2022 | finance.yahoo.comNantHealth Third Quarter 2022 Earnings: US$0.12 loss per share (vs US$0.094 loss in 3Q 2021)November 4, 2022 | finance.yahoo.comNantHealth Reports 2022 Third Quarter Financial ResultsNovember 1, 2022 | finance.yahoo.comNantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3October 16, 2022 | fool.comNantHealth, Inc. (NASDAQ: NH)October 11, 2022 | finance.yahoo.comWellStack Expands Executive Team with Chief Revenue Officer Christopher Rogowski - Yahoo FinanceOctober 5, 2022 | benzinga.com11 Health Care Stocks Moving In Wednesday's Pre-Market Session - Applied DNA Sciences (NASDAQ:APDN), Aven - BenzingaSeptember 27, 2022 | globenewswire.comGlobal Respiratory Care Devices Market expanding at a high-value CAGR of 8.3% by the end of 2032 - GlobeNewswireSeptember 9, 2022 | uk.investing.comWhy ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday By Benzinga - Investing.com UKSeptember 5, 2022 | bizjournals.comBillionaire's Morrisville firm tries to forestall stock delisting from the NasdaqAugust 24, 2022 | businesswire.comNantHealth's Eviti Platform Once More Earns Full URAC Accreditation Through 2025 - Business WireAugust 24, 2022 | finance.yahoo.comNantHealth’s Eviti Platform Once More Earns Full URAC Accreditation Through 2025August 12, 2022 | finance.yahoo.comSarah Chavarria Named President of Delta Dental of California and Affiliates - Yahoo FinanceAugust 5, 2022 | fool.comNantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript - The Motley FoolAugust 5, 2022 | finance.yahoo.comNantHealth, Inc. (NH) Q2 2022 Earnings Call TranscriptAugust 4, 2022 | businesswire.comNantHealth Reports 2022 Second Quarter Financial Results - Business WireAugust 4, 2022 | finance.yahoo.comNantHealth Reports 2022 Second Quarter Financial ResultsAugust 1, 2022 | finance.yahoo.comNantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 - Yahoo FinanceSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive NH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter. Email Address NH Company Calendar Last Earnings11/04/2021Today3/21/2023Next Earnings (Estimated)3/23/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Data processing & preparation Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NH Previous SymbolNYSE:NH CUSIPN/A CIK1566469 Webwww.nanthealth.com Phone(310) 883-1300FaxN/AEmployees326Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($7.6462) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-58,260,000.00 Net Margins-89.76% Pretax Margin-89.67% Return on EquityN/A Return on Assets-30.69% Debt Debt-to-Equity RatioN/A Current Ratio0.36 Quick Ratio0.36 Sales & Book Value Annual Sales$62.65 million Price / Sales0.23 Cash FlowN/A Price / Cash FlowN/A Book Value($21.04) per share Price / Book-0.09Miscellaneous Outstanding Shares7,710,000Free Float2,983,000Market Cap$14.44 million OptionableOptionable Beta1.86 Key ExecutivesPatrick Soon-ShiongChairman & Chief Executive OfficerRonald Allen LouksChief Operating OfficerBob PetrouChief Financial OfficerTiffany AveryChief Medical OfficerBrandon VillerySecretary, Senior VP-Legal, VP & General CounselKey CompetitorsInfinity PharmaceuticalsNASDAQ:INFILexaria BioscienceNASDAQ:LEXXHumanigenNASDAQ:HGENelectroCoreNASDAQ:ECORCNS PharmaceuticalsNASDAQ:CNSPView All CompetitorsInstitutional OwnershipMillennium Management LLCSold 211,402 shares on 2/15/2023Ownership: 0.131%Geode Capital Management LLCSold 381,139 shares on 2/13/2023Ownership: 0.352%Simplex Trading LLCSold 1,000 shares on 2/2/2023Ownership: 0.000%View All Institutional Transactions NH Stock - Frequently Asked Questions How have NH shares performed in 2023? NantHealth's stock was trading at $3.65 at the beginning of the year. Since then, NH shares have decreased by 48.7% and is now trading at $1.8735. View the best growth stocks for 2023 here. Are investors shorting NantHealth? NantHealth saw a increase in short interest in February. As of February 28th, there was short interest totaling 51,000 shares, an increase of 17.5% from the February 13th total of 43,400 shares. Based on an average trading volume of 104,100 shares, the short-interest ratio is currently 0.5 days. Currently, 2.0% of the company's stock are short sold. View NantHealth's Short Interest. When is NantHealth's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, March 23rd 2023. View our NH earnings forecast. How were NantHealth's earnings last quarter? NantHealth, Inc. (NASDAQ:NH) released its earnings results on Thursday, November, 4th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.08) by $0.02. The business earned $14.36 million during the quarter, compared to analysts' expectations of $17.70 million. During the same period in the prior year, the company posted ($0.08) EPS. What is Patrick Soon-Shiong's approval rating as NantHealth's CEO? 82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of NantHealth own? Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX). When did NantHealth IPO? (NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers. What is NantHealth's stock symbol? NantHealth trades on the NASDAQ under the ticker symbol "NH." Who are NantHealth's major shareholders? NantHealth's stock is owned by a number of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.35%), Millennium Management LLC (0.13%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Patrick Soon-Shiong and Ronald Allen Louks. View institutional ownership trends. How do I buy shares of NantHealth? Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is NantHealth's stock price today? One share of NH stock can currently be purchased for approximately $1.87. How much money does NantHealth make? NantHealth (NASDAQ:NH) has a market capitalization of $14.44 million and generates $62.65 million in revenue each year. The company earns $-58,260,000.00 in net income (profit) each year or ($7.6462) on an earnings per share basis. How many employees does NantHealth have? The company employs 326 workers across the globe. How can I contact NantHealth? NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (310) 883-1300 or via email at ir@nanthealth.com. This page (NASDAQ:NH) was last updated on 3/21/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.